Home - Valneva
Valneva is a specialty vaccine company focused on the development, manufacturing and commercialization of prophylactic vaccines for infectious diseases with significant unmet …
仅显示来自 valneva.com 的搜索结果Products
Valneva. About Us. About Us Advancing vaccines for better lives Learn More. …
Media
Valneva Reports High Sustained Immune Response in Adolescents One Year …
About Us
We are a specialty vaccine company that …R&D
Valneva’s vaccine candidate, VLA1601, is a highly purified inactivated vaccine …
Investors
Valneva is a specialty vaccine company …
Careers
I am leading teams responsible for managing clinical studies for our vaccine …
Japanese Encephalitis Vaccine
IXIARO®, or JESPECT® in Australia and New Zealand, is an inactivated …
Cholera Vaccine
Valneva’s cholera vaccine DUKORAL® is an oral vaccine indicated for the …
Marketing and Distribution
Countries served directly by in-house commercial operations currently …
Manufacturing and Services
The site has a long tradition of vaccine manufacturing connected to Sweden’s …
Valneva COVID-19 vaccine - Wikipedia
Valneva COVID-19 vaccine is a COVID-19 vaccine developed by French biotechnology company Valneva SE in collaboration with the American biopharmaceutical company Dynavax Technologies.
In April 2022, the United Kingdom Medicines and Healthcare products Regulatory Agency (MHRA) approved the vaccine, being the first in the world to do so. It was approved for medical use in th…Wikipedia · CC-BY-SA 许可下的文字- bing.com › videos观看完整视频观看完整视频
Valneva Provides Clinical and Regulatory Updates for its COVID-19 ...
2023年3月2日 · VLA2001 is produced on Valneva’s established Vero-cell platform, leveraging the manufacturing technology for Valneva’s licensed Japanese encephalitis vaccine, IXIARO ®. …
The Valneva VLA2001 COVID-19 vaccine: What you need to know
- Given the adverse consequences of COVID-19 disease during pregnancy and the favorable safety profile of Valneva, WHO recommends the use of Valneva in pregnant individuals. WHO does not recommend pregnancy testing prior to vaccination. WHO does not recommend delaying pregnancy or terminating pregnancy because of vaccination. Vaccine effectiveness is...
Valneva SE - Wikipedia
Vaccines marketed by Valneva include Ixiaro, a vaccine against Japanese encephalitis (approved in Europe, America and Australia) and Dukoral, a vaccine against cholera (approved in Europe and Australia).
Some of its candidates have failed in clinical trials: VLA43, a therapeutic vaccine against Pseudomonas aeruginosa, V710, a therapeutic vaccine against Staphylococcus aureus (in colla…Wikipedia · CC-BY-SA 许可下的文字- 预计阅读时间：6 分钟
R&D - Valneva
Valneva’s vaccine candidate, VLA1601, is a highly purified inactivated vaccine candidate against the Zika virus, developed using the same manufacturing platform as Valneva’s Japanese encephalitis vaccine.
Immunogenicity and safety of an inactivated whole …
2022年9月5日 · The Valneva COVID-19 vaccine (VLA2001; Valneva Austria, Vienna, Austria) is an inactivated whole-virus, adjuvanted SARS-CoV-2 vaccine. We aimed to assess the safety and immunogenicity of primary vaccination …
2022年8月18日 · The COVID-19 Valneva (VLA2001) vaccine is a highly purified, inactivated, and adjuvanted whole virus SARS-CoV-2 vaccine. The whole-virion inactivated vaccine is …
Interim recommendations for use of the Valneva VLA2001 vaccine …
2022年8月18日 · These WHO interim recommendations for use of the Valneva VLA2001 vaccine were developed on the basis of advice issued by the Strategic Advisory Group of Experts on …
The Valneva COVID-19 vaccine: Why it might be a …
2021年11月9日 · Rather than induce an immune response that targets just the spike protein of the coronavirus, the Valneva vaccine, also known as VLA2001, stimulates an immune response to the entire virus, and ...
